Concepts & Glossary
Health and Wellness MLM Companies: How to Evaluate One
Health and wellness is the largest category in direct selling for structural reasons, and it carries the heaviest claim regulation. This covers why the category dominates, what to check on any company in it, and the sources worth using instead of a list.
This article does not rank health and wellness companies, and the reason is worth stating up front.
Ranking wellness products means making substantive claims about efficacy. We build software for direct selling companies; we are not qualified to assess a supplement, and we would be commercially conflicted if we tried, since the companies on any such list are potential clients or competitors of our clients.
What we can do without overreaching: explain why this category dominates the industry, what is genuinely different about operating in it, what to check on any specific company, and which primary sources a useful answer would have to be built from.
Nothing here is medical or legal advice. Claim regulation differs by country and by product classification, and a specific product question belongs with a regulatory consultant or lawyer in your market.
Why this category dominates
Health, nutrition and wellness is the largest product category in direct selling in most markets, and the reason is economic rather than cultural. Three properties line up:
The products are consumable. They get used up and reordered, which produces recurring revenue for the company and something that can honestly be described as residual for the field. A durable product bought once every eight years cannot support the same plan.
The gross margins are wide enough to fund a multi-level payout. A direct selling plan pays out a substantial share of commissionable volume across all its components. That is only possible where the margin exists, and supplements have it in a way that, say, consumer electronics does not.
The products are experiential and hard to compare on a shelf. Two supplements with similar labels may be genuinely different, and most buyers cannot tell from the packaging. That makes a personal recommendation valuable in a way it is not for a commodity.
Any category with those three tends to attract direct selling. Wellness has all three more strongly than almost anything else, which is why cosmetics and personal care — the next closest on all three counts — are the second largest category.
What is genuinely different about operating here
One thing, and it is significant: a claim about a health product is regulated speech, and in this model it is made by thousands of people you do not employ.
In most jurisdictions, saying a product treats, prevents or cures a condition moves it out of the supplement category and into a regulated one. The company knows this. The distributor writing an enthusiastic post at eleven at night does not, or does and does not think it applies to them.
Three specific exposures:
Health claims at unreviewable volume. No review process staffed by humans can keep pace with what a field of several thousand people publishes. That is not a resourcing problem to be solved with more reviewers; it is a structural fact that has to be designed around.
Income claims paired with health claims. The combination — this product changed my health and gave me this income — draws more regulatory attention than either alone, because it is the shape of the pitch regulators have written about most.
Testimonials. A genuine personal account of a health outcome functions as a claim about the product. It being true for that person does not change what it does when published as marketing.
The control that works
Not a policy document. Policies help and they do not prevent.
The control that works is an approved claims library built as a permission rather than a prohibition: a set of specific things a distributor may say, available in the tools they already use, so the fastest path to writing a post is also the reviewed one. A prohibition without a provided alternative produces workarounds, and the workarounds are what you end up defending.
Alongside it: monitoring of the replicated pages you host, because those are yours, and a versioned record of which policy version each distributor accepted. We cover how this is built on the health and wellness software page.
What to check on a specific company
Five checks. None require insider access.
1. Are the label claims specific and evidenced? “Supports normal immune function, per the ingredient dossier” is a claim somebody stands behind. “Boosts your body’s natural defences” is carefully constructed to say very little. “Changed my life” is not a claim about the product at all. Ask what sits behind each claim: a supplier dossier, a published study on that ingredient at that dose, or nothing.
2. Will the company name its manufacturing standard? Companies manufacturing to a recognised standard generally say so and will identify it. A vague reference to quality without a named standard is a choice.
3. What does it cost relative to an ordinary retail equivalent? It will be higher — the price has to fund the plan. That is not automatically bad value. What matters is whether the difference buys you something real, and whether the company’s own material claims to be cheaper than retail, which sets the field up to lose arguments in public.
4. What proportion of revenue comes from people who are not participants? The most informative number about any direct selling company, and in a consumable category it is answerable — reorders by customers with no financial interest in reordering are the whole point of the model.
5. Does reorder behaviour track consumption or qualification deadlines? If reorders cluster before rank cut-offs, the product is being bought to hold a rank. A company with good data knows this about itself.
And the test that cuts through all five: would you buy it at that price with no compensation plan attached? If the answer depends on the plan, you are evaluating a business opportunity rather than a product. That is a legitimate thing to evaluate — do it with the income data in front of you.
The sources worth using
For company size and revenue: Direct Selling News publishes an annual global revenue ranking, which most online lists are downstream of. For publicly traded companies or those with a publicly traded parent, SEC filings contain audited revenue, participant counts and — most usefully — the company’s own risk factor disclosures about its regulatory and field exposure.
For conduct: published Federal Trade Commission actions and press releases, and state attorney general announcements, both searchable. Actions in this category frequently concern health or income claims specifically, and the complaints describe the conduct in detail.
For product regulation: the relevant national regulator’s own database and warning-letter publications. In the US that is the Food and Drug Administration for supplement labelling and the FTC for advertising claims; other markets have their equivalents. Warning letters are public and are the most specific evidence available about what a regulator considered unacceptable.
For participant outcomes: the company’s own income disclosure statement. Read the median rather than the mean, check whether the denominator includes everyone who held a position or only the “active”, and note whether figures are gross or net of the participant’s own purchases.
How to check a specific company is the general version of this process, and MLM companies in the USA covers the US sources in more depth.
If you are launching in this category
The category’s economics are the best in direct selling and its compliance surface is the worst. Both facts are structural and neither is a reason to avoid it.
Three things to build rather than to write policies about:
- The approved claims library, as a permission, in the tools the field already uses.
- Order classification at the point of sale — retail customer, preferred customer, distributor purchase — because it cannot be reconstructed later and it is the record everything else depends on.
- Per-market product availability that also controls volume. A product not cleared in a market must not be orderable there and must not contribute commissionable volume there. Enforcing the first without the second produces distributors who qualified on orders that were never fulfilled.
The health and wellness page covers all three, and types of MLM companies covers how the consumable reorder model differs from the other three revenue shapes.
Questions operators ask before they switch
Straight answers on plan mechanics, migration risk and compliance. If yours is not here, ask us directly.